ecteinascidin 743 has been researched along with Lymphoma, Large B-Cell, Diffuse in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertoni, F; Cascione, L; Chung, EY; D'Incalci, M; Erba, E; Gatta, R; Panini, N; Rinaldi, A; Spriano, F; Stathis, A | 1 |
1 other study(ies) available for ecteinascidin 743 and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Trabectedin is a novel chemotherapy agent for diffuse large B cell lymphoma.
Topics: Antineoplastic Agents; Cell Line, Tumor; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Trabectedin; Transcription, Genetic | 2019 |